Lincil

Quick links to important sections

Lincil

Method of action: Antihypertensive

Treatment option: Hypertension, Angina Pectoris

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lincil

What is Lincil? An Overview

Here is a concise overview of Lincomycin (Lincil), the fundamental facts about its nature, origin, and general therapeutic role.

Quick Facts about Lincil
Active Ingredient Lincomycin
Common Forms Capsule, Injection (Solution)
Pharmacological Class Lincosamide Antibiotic
Origin Derived from the bacterium Streptomyces lincolnensis
General Purpose Treating serious bacterial infections

What Type of Medicine is Lincil?

Lincil is classified as a lincosamide antibiotic used to treat serious bacterial infections. This classification means Lincil is part of a distinct group of antibiotics that target and inhibit bacterial protein synthesis by interfering with the microbial machinery necessary for growth.

The compound, known chemically as Lincomycin, was originally isolated from the soil bacterium Streptomyces lincolnensis. Pharmacological studies have confirmed its efficacy against a range of Gram-positive bacteria. This established history and unique mechanism differentiate it from newer or broader-spectrum antibiotics.


What is Lincil Made Of and What Form Does It Take?

The core composition of the medicine is the active ingredient, Lincomycin, typically formulated for oral administration as a capsule or for use as an injectable solution. Lincomycin is a highly purified, crystalline substance.

The final medicinal product can take various forms depending on the target application. The injectable solution is a key feature of the lincosamide class, designed for rapid systemic delivery in acute care settings. When administered as an oral capsule, the formulation ensures the active ingredient is protected until it reaches the necessary absorption site in the gastrointestinal tract.


What is the General Purpose of Lincil?

The general purpose of Lincil (Lincomycin) is to eliminate susceptible bacteria and halt the progression of serious, often life-threatening, infections caused by those organisms. As a targeted antibacterial agent, Lincil’s therapeutic purpose is selective. It is frequently reserved for situations where first-line treatments are inappropriate, such as treating certain severe bone and joint infections. This ensures that Lincil is utilized strategically where its unique action provides the greatest benefit.

What side effects are possible with Lincil?

Possible Side Effects and Safety Information

The official safety profile for Lincomycin (Lincil) is primarily characterized by the risk of specific Gastrointestinal Disorders and the potential for serious, systemic adverse reactions across several System-Organ Classes (SOCs).

Adverse Reaction Groupings

The most frequently documented SOC category is Gastrointestinal Disorders, which includes common effects such as diarrhea, nausea, and vomiting. However, the most serious safety concern is the risk of Clostridioides difficile-Associated Diarrhea (CDAD), or Pseudomembranous Colitis, a condition highlighted with a high-level regulatory warning due to its potential severity. This complication may be reported with a delayed onset, up to two months following the cessation of the drug.

Other systems involved include Blood and Lymphatic System Disorders (e.g., Agranulocytosis, Aplastic Anemia) and Immune System Disorders (e.g., Anaphylaxis, Angioedema). Skin reactions may range from common rash to rare, severe cutaneous adverse reactions (SCARs) like Stevens-Johnson Syndrome (SJS).

Specific Safety Constraints

The regulatory profile specifies several constraints based on administration and patient population. Rapid intravenous infusion is explicitly associated with an acute risk of hypotension and Cardio-respiratory arrest.

Caution is advised for patients with severe hepatic or renal impairment because the drug’s half-life may be prolonged, which can affect overall exposure. Furthermore, the use of injectable formulations in neonates and infants requires consideration of the risk of Gasping Syndrome if the product contains benzyl alcohol. The overall safety structure emphasizes that official risk assessment is tied to administration technique and pre-existing patient conditions.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory labeling for Lincomycin (Lincil) describes potential overdose through its documented clinical manifestations and required emergency actions. Overdosage may be associated with an increased risk of severe adverse events, particularly exaggerated gastrointestinal effects, including abdominal pain, nausea, vomiting, and diarrhea. Severe outcomes documented in official sources include hypotension and cardio-respiratory arrest, which are noted in relation to intravenous administration at concentrations or rates greater than those recommended.


Required Emergency Response

Immediate medical attention is required for suspected overdosage. Regulatory guidance instructs patients to get medical help right away, call emergency services, or contact a Poison Control center. Overdose management is focused on supportive care, as no specific antidote is known. The official procedural measures include simple gastric lavage alongside symptomatic and supportive measures. It is officially stated that methods such as hemodialysis or peritoneal dialysis are not effective for removing Lincomycin from the blood.


Population Risk

The injectable formulation contains benzyl alcohol, which has been associated with severe toxicity, including Gasping Syndrome, particularly in infants and low birth weight pediatric patients. Additionally, the drug’s half-life is prolonged in cases of severe renal or hepatic impairment, which is a critical consideration for overdose management.

Therapeutic Uses of Lincil

What Lincil Treats: Main Uses and Benefits

Lincil is commonly used in situations involving certain distressing symptoms and is applied across domains where additional symptomatic support is needed. Its main role is to help patients manage the intensity and burden of challenging symptoms, especially during episodes where short-term symptomatic assistance is appropriate. The medication is relevant for easing discomfort related to systemic imbalance and for managing symptoms that create noticeable interference with daily comfort, which are symptom patterns common in conditions where functional stability becomes affected. The therapeutic domain is aligned with established guidance on symptom management, often utilized in clinical settings that involve acute or unstable symptom patterns. Conditions involving persistent gastrointestinal discomfort often require specific interventions to ease the symptom load.

Lincil is relevant for managing conditions characterized by episodic or fluctuating symptom patterns, including presentations where symptoms cluster into patterns requiring additional symptomatic support. It supports patients during difficult episodes by easing distress, especially for symptoms that may become difficult to tolerate. The primary therapeutic focus may be on supportive relief during acute or disruptive episodes where symptoms intensify and functional stability becomes affected.

Quick Fact

Symptom Focus: Managing Heightened Manifestations

Lincil is often used when symptoms intensify and supportive relief is needed, may assist with maintaining functional stability during symptomatic phases.

Eligibility and Restrictions for Use

Who can and cannot use Lincil?

Lincil (Lincomycin) is permitted for use by adults and children over one month of age, often reserved for individuals with serious bacterial infections who are allergic to penicillin. However, its use is strictly regulated by official documentation.

Population Status Restriction or Rule
Contraindicated Patients with known hypersensitivity to lincomycin or clindamycin, and patients requiring treatment for meningitis or nonbacterial (viral) infections.
Age-Related Limits The injection form is restricted in newborns and children under three years old due to preservative content and recommended duration limits, respectively. Older adults with associated illness require close monitoring.
Conditional Use Caution is required for patients with severe impairment of renal (kidney) or hepatic (liver) function, as well as a history of gastrointestinal diseases, particularly colitis.
Life-Stage Status Use during pregnancy and breastfeeding is generally conditional and requires caution, especially with formulations containing benzyl alcohol.

The eligibility profile dictates that Lincil must be reserved exclusively for the documented patient population as defined by the official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific, mandatory constraints for co-administration of Lincil (Lincomycin) with other products, based on documented pharmacological and pharmacokinetic patterns.


Documented Interaction Patterns

Category Description of Official Regulatory Constraint
Pharmacodynamic Antagonism Co-administration with Macrolide Antibiotics (e.g., Erythromycin) is prohibited due to the risk of in vitro antagonism, which may reduce effectiveness.
Pharmacodynamic Potentiation Lincil possesses neuromuscular blocking properties that may enhance the action of other Neuromuscular Blocking Agents.
Physical Incompatibility Novobiocin and Kanamycin are physically incompatible when combined with Lincil in an infusion solution, necessitating separation of administration.

Exposure and Population-Specific Restrictions

Regulatory labeling highlights specific conditions that alter the drug's clearance. The serum half-life of Lincil is prolonged in patients with severe renal impairment or abnormal hepatic function.

Additionally, the regulatory documents contain cautions regarding the Benzyl Alcohol preservative found in the injectable formulation. The metabolic load of this excipient must be carefully considered in neonates and in patients with underlying liver or kidney impairment.

Mechanism of Action

How Lincil Works: Mechanism of Action

Lincil (a lincosamide) inhibits the creation of proteins, a fundamental biological process of susceptible bacteria.


Inhibition of Bacterial Protein Synthesis

Lincil targets the 23S ribosomal RNA (rRNA) component within the 50S subunit of the bacterial ribosome. This binding blocks the peptidyl transferase center, preventing the necessary enzymatic reaction that links amino acids together. This action stops the elongation of nascent polypeptide chains, thereby limiting the production of complete, functional proteins.


Selective Mechanistic Action and Physiological Effect

This mechanism exhibits selective toxicity by binding only to prokaryotic (bacterial) ribosomes, which are structurally distinct from eukaryotic (human) ribosomes. This selective action results in the bacteriostatic (growth-inhibiting) physiological effect on the bacterial population.


Mechanistic Basis for Resistance

Resistance mechanisms, such as the methylation of the A2058 residue on the 23S rRNA, alter the drug's precise binding site. This alteration physically prevents Lincil from binding and exerting its inhibitory effect, directly influencing the observed spectrum of activity.

Dosage and Administration Information

How to Use Lincil Oral Suspension: Official Administration Guidelines

Lincil is an oral suspension prescribed for use in adults. Administration must strictly follow the official instructions for dosing, timing, and preparation.

Route of Administration and Dosing

The approved route of administration is oral or via Percutaneous Endoscopic Gastrostomy tubes (PEG-tubes). The standard dosage is 50 mg (10 mL), taken twice daily, approximately every 12 hours. The dose must be taken at least 1 hour before or 2 hours after a meal.


Procedural and Monitoring Requirements

Preparation: The Lincil bottle must be gently shaken for a minimum of 30 seconds prior to each administration to ensure proper dosing.

Special Conditions: The use of Lincil is not recommended for patients with severe hepatic impairment (transaminases greater than 5 times the Upper Limit of Normal [ULN]). Serum aminotransferases must be measured before initiating treatment and monitored every month for the first three months of treatment, and periodically thereafter.

Official Step Sequence:

  • Monitor serum aminotransferases prior to starting treatment.
  • Gently shake the Lincil bottle for at least 30 seconds.
  • Administer the 50 mg (10 mL) dose either by mouth or through a PEG-tube.
  • Observe the required timing: at least 1 hour before or 2 hours after a meal.
  • Repeat the 50 mg (10 mL) dose 12 hours after the first dose.
  • Continue to monitor serum aminotransferases monthly for the first 3 months, then periodically.

This structure outlines the required steps for administering Lincil, defining the required preparation, specific dosing frequency, and laboratory monitoring that governs the use protocol.

Recent Clinical Evidence

Research evidence / Overview of Studies for Lincil

The scientific evidence for Lincomycin (Lincil) is based primarily on studies of its use as an antibiotic against serious bacterial infections, dating from its initial development and continuing through observational research. These studies help show what has been observed so far regarding how the medicine was studied against specific types of bacteria.


Evidence for Use in Serious Bacterial Infections

The foundational evidence for Lincil comes from both historical Randomized Controlled Trials (RCTs) and in vitro laboratory studies. RCTs were used to compare Lincil with other older antibiotics to examine outcomes related to the management of severe infections caused by susceptible Gram-positive bacteria. Researchers monitored clinical endpoints, such as tracking the change in signs and symptoms of infection like fever, and microbiological endpoints, which involved assessing whether the targeted bacteria were tracked at the site of infection.

Studies examined measurements related to the change in infection status and the rate at which the targeted bacteria were tracked. However, since much of this evidence is historical, limited contemporary comparative data are available from recent large-scale RCTs against newer generations of antibiotics. Research is ongoing to track the development of increasingly resistant bacterial strains.


Evidence for Use in Deep-Seated Bone and Joint Infections

Lincomycin was evaluated in research exploring its use against complex, deep-seated infections such as osteomyelitis (bone infection). The evidence is built mainly on prospective and retrospective observational cohort studies and systematic reviews. Researchers monitored long-term change in infection status and measured the frequency of infection recurrence (relapse), sometimes for six months or more.

What remains uncertain is that many studies for this specific use have modest sample sizes and non-randomized study designs, which can lead to high variability in reported findings. There is also difficulty in isolating the effect of the antibiotic from other treatments, such as concurrent surgical procedures.

Key Studies & References

  1. Lincomycin Pharmacokinetic Properties and Cerebrospinal Fluid Diffusion

Frequently Asked Questions (FAQ)

Common questions about Lincil (FAQ)


Q: What is the main difference between Lincil and similar prescription medicines?

Official information defines Lincil (Lincomycin) as being part of the lincosamide class of antibiotics. Its unique mechanism of action, which involves stopping bacteria from creating proteins by binding to a specific part of the bacterial ribosome, is how it is primarily defined and distinguished from other types of antibiotics.


Q: Does Lincil have a boxed warning in official documents?

Yes, official labeling contains a Boxed Warning. This warning is used by regulatory bodies to highlight the risk of severe diarrhea, specifically Clostridioides difficile-Associated Diarrhea (CDAD), which is cited as a high-level safety concern in the official labeling.


Q: Does Lincil interact with any common foods or drinks?

Official administration instructions require Lincil to be taken at specific times—at least 1 hour before or 2 hours after a meal. This timing requirement is noted in the regulatory documents to manage the drug's absorption. However, regulatory documents do not list any specific chemical interactions where common foods or drinks change the drug's effect.


Q: Are there different forms or strengths of Lincil available?

Yes, Lincil is officially available in different medicinal forms, such as oral capsules and injectable solutions. These forms are supplied in a variety of strengths as described in the official product information.


Q: Is Lincil an addictive or habit-forming medicine?

No. Lincil (Lincomycin) is classified as an antibiotic. It is not considered to be an addictive medicine, nor is it classified as a controlled substance by major regulatory authorities like the U.S. Drug Enforcement Administration.


Q: What is the risk of having an allergic reaction to Lincil?

Official documents list known hypersensitivity (a severe allergic reaction) to Lincil is listed as a contraindication for its use. Serious allergic reactions, including anaphylaxis (a severe, whole-body reaction), are cited as potential adverse events, underscoring the risk.


Q: What does 'contraindication' mean in relation to Lincil?

A contraindication is a critical safety term used in official regulatory documents. It means that there is a specific condition or circumstance, such as a known allergy to the drug, where the use of Lincil is officially advised against.


Q: What is the half-life of Lincil?

The half-life refers to the time it takes for the concentration of the medicine in the body to be reduced by half. Official pharmacokinetic data reports the biological half-life of Lincil to be approximately 5.4 pm 1.0 hours in individuals with normal kidney and liver function.


Q: What does the FDA label say about Lincil's effectiveness?

The official product label states that Lincil is indicated for the treatment of serious infections. The approved use is directed specifically against susceptible strains of certain bacteria, including types of streptococci, pneumococci, and staphylococci.


Q: What is the difference between a side effect and an adverse reaction for Lincil?

Regulatory documents typically group all unwanted effects under the term 'Adverse Reactions.' This umbrella term includes both common and expected events, such as a mild rash (often called a side effect), and more serious or unexpected events, such as an internal system disorder.


Q: Does Lincil expire, and does it become unsafe after the expiration date?

Lincil, like all medications, has a documented expiration date, and official guidelines mandate the disposal of expired product. The use of any medicine past its expiration date is not supported by manufacturers or regulatory bodies because the full safety, purity, or effectiveness can no longer be guaranteed.


Q: How quickly should someone expect Lincil to start working?

Official pharmacokinetic data indicates that peak concentrations of the drug in the bloodstream are typically observed around 60 minutes after administration of an injection. This is the time point where the highest amount of the medicine is present in the body.


Q: Is it common to feel tired when starting Lincil?

The official list of potential adverse reactions includes effects on the nervous system, such as somnolence (which means drowsiness or sleepiness). Drowsiness is a documented reaction that may be experienced by some patients.


Q: Are there any side effects of Lincil that are considered rare?

Official documents list several severe adverse reactions, such as Agranulocytosis (a serious blood disorder) and Stevens-Johnson Syndrome (a severe skin reaction). Official documents categorize these specific, severe effects as being rare based on clinical data.


Q: Can Lincil affect my ability to drive or operate machinery?

The drug’s adverse reaction profile lists potential neurological effects such as dizziness, headache, and somnolence (drowsiness). Any of these effects could potentially impair concentration or physical coordination. Official sources recommend awareness of these effects.


Q: Are there any studies looking at Lincil use in older adults?

Official general precautions mention that subgroups of older patients with severe associated illnesses may tolerate adverse effects less well. Official guidance includes the recommendation that these patients undergo close monitoring for changes in bowel function due to the risk of severe diarrhea.


Q: Why do official sources list specific groups of people who cannot use Lincil?

Official sources list contraindications and warnings based on specific patient groups. The purpose of this is to communicate the risk of known, severe adverse reactions, such as allergic shock, or complications in infants related to certain inactive ingredients.


Q: If I miss a dose of Lincil, what is the general recommendation?

Instructions commonly found in regulatory documentation describe the general process for a missed dose. This typically involves taking the missed dose if remembered soon, or skipping it entirely if the next dose is almost due, in order to avoid taking extra medication.


Q: What are the main results of the Phase 3 clinical trials for Lincil?

Official documentation outlines that the evidence is based on clinical trials that monitored two key areas. These were changes in the signs and symptoms of infection (known as clinical endpoints) and the tracking of targeted bacteria (known as microbiological endpoints).


Q: Does Lincil come with a patient information leaflet?

Yes. All prescription drugs are required by regulatory mandates to be dispensed with specific documentation. This information ensures that patients have access to the official Patient Information Leaflet (PIL) or a Medication Guide with key safety facts.


Q: Can Lincil affect birth control pills?

Regulatory documents do not specifically cite a drug interaction between Lincil and hormonal contraceptives. However, some types of broad-spectrum antibiotics are associated with a potential for reduced effectiveness of birth control, which is a general consideration noted in medical literature.


Q: Is Lincil a controlled substance?

No, Lincil (Lincomycin) is an antibiotic used to treat bacterial infections. It is not classified as a controlled substance under the U.S. Controlled Substances Act or similar international regulatory frameworks.


Q: What are the alternatives to Lincil mentioned in medical literature?

Official documents state that the drug should generally be reserved for use when other alternatives are inappropriate, such as in penicillin-allergic patients. For instance, the labeling explicitly mentions that an alternative like erythromycin may be considered an alternative choice.


Q: What is the purpose of the long list of potential side effects for Lincil?

The extensive list is required by regulatory agencies to ensure transparency. It informs healthcare providers and patients of all known adverse events observed during clinical use and trials. The list is intended to provide a comprehensive summary of observed events for informational purposes.


Q: Is Lincil effective if taken inconsistently?

Official dosing instructions emphasize adherence to the prescribed schedule, such as taking the drug twice daily. This is necessary to maintain the therapeutic concentration of the medicine. Inconsistent use is a factor that may prevent the drug from maintaining effective levels needed to address the infection.

How should Lincil be stored and disposed of?

How to Store and Dispose of Lincil?

Regulatory documents mandate specific conditions for storing and disposing of Lincomycin (Lincil) to maintain product stability and ensure public safety.

Official Storage Requirements

Lincil must be stored at Controlled Room Temperature, which is typically 20 C to 25 C (68 F to 77 F), though some forms allow storage below 30 C. It is mandatory to protect the medicine from light and moisture and to keep the container tightly closed in its original packaging. Lincomycin must not be frozen.

Child Safety and Disposal

It is required to keep Lincil out of the sight and reach of children.

Unused or expired product must not be disposed of in household waste or flushed down the toilet due to potential environmental harm. Disposal must be performed according to local regulations, often through a medicine take-back program or pharmacy-operated system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lincil found in:

A-Z Index: